China Pharma (NYSE:CPHI) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIFree Report) in a report issued on Wednesday. The firm issued a hold rating on the stock.

China Pharma Stock Up 16.2 %

China Pharma stock opened at $0.23 on Wednesday. The firm has a 50 day simple moving average of $0.21 and a 200 day simple moving average of $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 1-year low of $0.13 and a 1-year high of $0.64.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.